Perfusion CT for the assessment of tumour vascularity: Which protocol?

British Journal of Radiology

Volumn 76, Issue SPEC. ISS. 1, 2003, Pages

  Miles, K A ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VOLUME; CALCULATION; CALIBRATION; CLINICAL PROTOCOL; COMPARTMENT MODEL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG MONITORING; IMAGE ANALYSIS; IMAGE PROCESSING; IN VIVO STUDY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PERMEABILITY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; REPRODUCIBILITY; RISK ASSESSMENT; TIME; TISSUE PERFUSION; TUMOR VASCULARIZATION; VALIDATION PROCESS;

AUTOMATIC DATA PROCESSING; CLINICAL PROTOCOLS; CONTRAST MEDIA; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RESPIRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 8844224812     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/18486642     Document Type: Article

References (45)

1. Miles KA, Griffiths MR, Comber L, Keith CJ, Fuentes M. Functional imaging of cancer: combining perfusion CT with FDG-PET. Cancer Imaging 2002;3:17-8.
2. Miles KA. Functional computed tomography in oncology. Eur J Cancer 2002;38:2079-84.
3. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003;76:220-31.
4. Swensen SJ, Viggiano RW, Midthun DE, Muller NL, Sherrick A, Yamashita K, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80.
5. Comber LA, Keith CJ, Griffiths MR, Miles KA. Solitary pulmonary nodules: impact of quantitative contrast enhanced CT on the cost-effectiveness of FDG-PET. Clin Radiol 2003;58:706-11.
6. Cuenod C, Leconte I, Siauve N, Resten A, Dromain C, Poulet B, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001;218:556-61.
7. Platt JF, Francis IR, Ellis JH, Reige KA. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology 1997; 205:49-53.
8. Sheafor DH, Killius JS, Paulson EK, DeLong DM, Foti AM, Nelson RC. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases? Radiology 2000;214:875-80.
9. Dugdale PE, Miles KA. Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol 1999;30:206-13.
10. Leggett DA, Miles KA, Kelley BB. Blood-brain barrier and blood volume imaging of cerebral glioma using functional CT: a pictorial review. Australas Radiol 1998;42: 335-40.
11. Dugdale PE, Miles KA, Kelley BB, Bunce IH, Leggett DAC. CT measurements of perfusion and permeability within lymphoma masses: relationship to grade, activity and chemotherapeutic response. J Comput Assist Tomogr 1999;23:540-7.
12. Hermans R, Lambin P, Van den Bogaert W, Haustermans K, Van der Goten A, Baert AL. Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997;44:159-62.
13. Miles KA, Colyvas K, Griffiths MR, Bunce IH. Colon cancer: risk stratification using perfusion CT. Eur Radiol 2004;14:Suppl. 2:129.
14. Ford J, Miles K, Hayball M, Bearcroft P, Bleehan N, Osborn C. A simplified method for measurement of blood-brain barrier permeability using CT: preliminary results and the effect of RMP-7. In: Faulkner K, et al, editors. Quantitative imaging in oncology. London: British Institute of Radiology, 1996:1-5.
15. Falk SJ, Ramsay JR, Ward R, Miles K, Dixon AK, Bleehen NM. BW12C perturbs normal and tumour tissue oxygenation and blood flow in man. Radiother Oncol 1994;32:210-7.
16. Harvey C, Dooher A, Morgan J, Blomley M, Dawson P. Imaging of tumour therapy responses by dynamic CT. Eur J Radiol 1999;30:221-6.
17. Harvey CJ, Blomley MJ, Dawson P, Morgan JA, Dooher A, Deponte J, et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr 2001;25:43-9.
18. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol 2000;7:800-11.
19. Mullani N, Herbst R, Abbruzzese J, Charnsangavej C, Kim E, Tran H, et al. 9:00 9:15. Antiangiogenic treatment with endostatin results in uncoupling of blood flow and glucose metabolism inhuman tumors. Clin Positron Imaging 2000;3:151.
20. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10:145-7.
21. Miles KA, Charnsangavej C, Lee F, Fishman E, Horton K, Lee T-Y. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7:840-50.
22. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993;188:405-11.
23. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. Am J Neuroradiol 1999;20:63-73.
24. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. Am J Neuroradiol 2000;21:462-70.
25. Hattori H, Miyoshi T, Okada J, Yoshikawa K, Arimizu N, Hattori N. Tumor blood flow measured using dynamic computed tomography. Invest Radiol 1994;29:873-6.
26. Gould RG, Lipton MJ, McNamara MT, Sievers RE, Koshold S, Higgins CB. Measurement of regional myocardial blood flow in dogs by ultrafast CT. Invest Radiol 1988;23:348-53.
27. Blomley MJ, Coulden R, Bufkin C, Lipton MJ, Dawson P. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest Radiol 1993; 28 Suppl. 5:S72-7.
28. Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995;19:424-33.
29. Gillard JH, Minhas PS, Hayball MP, Bearcroft PW, Antoun NM, Freer CE, et al. Assessment of quantitative computed tomographic cerebral perfusion imaging with H2(15)O positron emission tomography. Neurol Res 2000; 22:457-64.
30. Wintermark M, Thiran JP, Maeder P, Schnyder P, Meuli R. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. Am J Neuroradiol 2001;22:905-14.
31. Nabavi DG, Cenic A, Dool J, Smith RM, Espinosa F, Craen RA, et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr 1999;23:506-15.
32. Gillard JH, Antoun NM, Burnet NG, Pickard JD. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 2001;74:552-5.
33. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE. Lung nodule enhancement at CT: prospective findings. Radiology 1996;201:447-55.
34. Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr 2001;25:23-7.
35. Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24:835-42.
36. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol 1999;30:198-205.
37. Roberts HC, Roberts TP, Smith WS, Lee TJ, Fischbein NJ, Dillon WP. Multisection dynamic CT perfusion for acute cerebral ischemia: the "toggling-table" technique. Am J Neuroradiol 2001; 22:1077-80.
38. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology 2001;220:548-53.
39. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997;205:471-8.
40. Yamashita K, Matsunobe S, Tsuda T, Nemoto T, Matsumoto K, Miki H, et al. Solitary pulmonary nodules: preliminary study of evaluation with incremental dynamic CT. Radiology 1995;194:399-405.
41. Miles KA, McPherson SJ, Hayball MP. Transient splenic inhomogeneity on contrast enhanced CT: mechanism and effect of liver disease. Radiology 1995;194:91-5.
42. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667-73.
43. Tsushima Y, Blomley JK, Kusano S, Endo K. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Digest Dis Sci 1999;44:1632-8.
44. Bader TR, Herneth AM, Blaicher W, Steininger R, Muhlbacher F, Lechner G, et al. Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology 1998;209:129-34.
45. Miles KA, Leggett DA, Bennett GA. CT derived Patlak images of the human kidney. Br J Radiol 1999;72:153-8.